Elizabeth Holmes Trial: Examining How Theranos Received Funding
Was it misguided confidence or fraud? The Elizabeth Holmes trial on Wednesday drilled down into how her company, Theranos, managed to grow into a $9 billion player in the biotech game without ever proving its machines worked. Scott Budman reports.